Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.40 – $0.90
3% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.10B | $9.60B | $15.52B | $20.58B | $26.76B | $27.03B | $30.60B | $33.03B |
| Cost of revenue | $3.77B | $7.37B | $11.90B | $16.47B | $21.06B | $21.13B | $23.17B | $25.12B |
| Gross profit | $1.33B | $2.23B | $3.62B | $4.11B | $5.70B | $5.90B | $7.43B | $7.92B |
| Gross margin | 26.1% | 23.2% | 23.3% | 20.0% | 21.3% | 21.8% | 24.3% | 24.0% |
| R&D | $219.0M | $252.8M | $423.6M | $728.8M | $677.8M | $705.4M | $720.1M | $760.2M |
| Operating income | −$98.2M | −$67.4M | $58.6M | −$1.10B | −$31.8M | $717.4M | $1.58B | $1.77B |
| EBITDA | −$94.2M | −$53.0M | $52.1M | −$188.1M | −$24.5M | $999.0M | $1.62B | $1.82B |
| Net income | −$81.9M | −$6.6M | $348.6M | −$265.6M | $535.7M | $883.5M | $1.43B | $1.87B |
| Net margin | -1.6% | -0.1% | 2.2% | -1.3% | 2.0% | 3.3% | 4.7% | 5.7% |
| EPS (diluted) | -0.01 | -0.00 | 0.03 | -0.02 | 0.04 | 0.06 | 0.09 | 0.11 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $39.1B | $0.13 | $0.13–$0.14 | 1 |
| 2028 | $43.4B | $0.16 | $0.15–$0.17 | 1 |
| 2029 | $48.5B | $0.18 | $0.17–$0.19 | 1 |
| 2030 | $95.4B | $0.52 | $0.49–$0.54 | 1 |
Forward consensus · source: Financial Modeling Prep
ALIBABA HEALTH INFO TECH
No one on the platform currently holds ALBHF.
No tracked institution reports a position in ALBHF as of their last filing.
No one on the platform has traded ALBHF yet.
| +0.00% |
| $11.0B |
| — |
| SARTFSartorius AG | $212.80 | +0.00% | $14.7B | — |
| SGIOFShionogi & Co., Ltd. | $18.80 | +0.00% | $16.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 3.0× earnings vs its 7.4× historical median P/E.
Fair value ≈ $1.03 · price $0.41 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.